Correlation Between Dianthus Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Kymera Therapeutics, you can compare the effects of market volatilities on Dianthus Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Kymera Therapeutics.
Diversification Opportunities for Dianthus Therapeutics and Kymera Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dianthus and Kymera is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Kymera Therapeutics
Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Kymera Therapeutics. In addition to that, Dianthus Therapeutics is 1.22 times more volatile than Kymera Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 4,089 in Kymera Therapeutics on November 2, 2024 and sell it today you would lose (44.00) from holding Kymera Therapeutics or give up 1.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dianthus Therapeutics vs. Kymera Therapeutics
Performance |
| Timeline |
| Dianthus Therapeutics |
| Kymera Therapeutics |
Dianthus Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dianthus Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite Dianthus Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Dianthus Therapeutics vs. Lion One Metals | Dianthus Therapeutics vs. Nicola Mining | Dianthus Therapeutics vs. Sphere Entertainment Co | Dianthus Therapeutics vs. Zijin Mining Group |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |